AMAG Pharmaceuticals Inc. no longer trades on any public stock exchange, meaning it does not have a current active market stock price. The company was acquired by Covis Pharma in a private all-cash transaction valued at approximately $498 million, which resulted in its complete delisting from the Nasdaq exchange. Because the buyout converted all outstanding public common stock into private equity liquidation rights, public market pricing ceased to exist when the transaction officially closed.